Description

[14As,(+)]-11,12,13,14,14Aα,15-Hexahydro-2,3,6-Trimethoxy-9H-Phenanthro[9,10-B]Quinolizine CAS NO 87302-53-2 is a complex, chiral alkaloid derivative belonging to the phenanthroquinolizine class of organic compounds. This compound is of significant interest for its potential as a key pharmaceutical intermediate and a sophisticated building block in advanced organic synthesis. It is primarily utilized by research institutions and industrial R&D departments focused on medicinal chemistry and the development of novel bioactive molecules.

Application

• Pharmaceutical Intermediate: Serves as a critical precursor in the research and development of new therapeutic agents, particularly those targeting neurological or anti-inflammatory pathways.
• Medicinal Chemistry Research: Used as a sophisticated scaffold or lead compound for structure-activity relationship (SAR) studies and drug discovery programs.
• Organic Synthesis Building Block: Employed in complex multi-step syntheses to construct intricate polycyclic frameworks due to its unique phenanthroquinolizine structure.
• Biochemical Research: Potential use as a tool compound or probe for studying biological mechanisms and enzyme interactions in academic and industrial laboratories.
• Reference Standard: Can be supplied as a high-purity standard for analytical method development, validation, and quality control in pharmaceutical analysis.

Basic Information

Product Name	[14As,(+)]-11,12,13,14,14Aα,15-Hexahydro-2,3,6-Trimethoxy-9H-Phenanthro[9,10-B]Quinolizine
CAS No.	87302-53-2
Molecular Formula	C24H27NO3
Molecular Weight	377.48 g/mol
Synonyms	(+)-14aS-Hexahydro-2,3,6-trimethoxy-9H-phenanthro[9,10-b]quinolizine; (14aS)-11,12,13,14,14a,15-Hexahydro-2,3,6-trimethoxy-9H-phenanthro[9,10-b]quinolizine; Phenanthro[9,10-b]quinolizine, 11,12,13,14,14a,15-hexahydro-2,3,6-trimethoxy-, (14aS)-; CAS 87302-53-2; (14aS)-Hexahydro-2,3,6-trimethoxyphenanthro[9,10-b]quinolizine
EINECS	Contact for details

Quality Control

Our [14As,(+)]-11,12,13,14,14Aα,15-Hexahydro-2,3,6-Trimethoxy-9H-Phenanthro[9,10-B]Quinolizine is produced and handled under a strict quality management system. Each batch undergoes rigorous analytical testing, including HPLC for purity and spectroscopic identification (IR, NMR), to ensure it meets exacting standards for research and development use. Comprehensive Certificates of Analysis (COA) detailing identity, purity, and impurity profiles are available upon request.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (typically 15-25°C). The product is light-sensitive and should be handled under appropriate conditions to maintain stability.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 95.0%
Specific Rotation	Contact for details
Loss on Drying	≤ 1.0%
Residue on Ignition	≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.